Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703543 | SCV000515641 | likely benign | not provided | 2019-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339000 | SCV002637405 | likely benign | Cardiovascular phenotype | 2020-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003647769 | SCV004520641 | likely benign | Long QT syndrome | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001703543 | SCV001978116 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001729583 | SCV001979241 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001703543 | SCV001979548 | likely benign | not provided | no assertion criteria provided | clinical testing |